GoHealth, Inc. (NASDAQ:GOCO) Receives Consensus Rating of “Hold” from Analysts


GoHealth, Inc. (NASDAQ:GOCO – Get Rating) has been assigned a consensus rating of “Hold” by the nine research companies that currently cover the business, Marketbeat.com reports. Three investment analysts rated the stock with a sell recommendation, five gave the company a hold recommendation and one gave the company a buy recommendation. The 1-year average price target among brokers who have hedged the stock over the past year is $3.50.

GOCO has been the subject of a number of analyst reports. Royal Bank of Canada downgraded GoHealth shares from an “outperforming” rating to an “sector outperforming” rating and lowered its price target for the company from $10.00 to $2.00 in a research report from Thursday, March 3. Morgan Stanley lowered its price target on GoHealth from $13.00 to $5.50 and set an “equal weight” rating for the company in a Thursday, November 11 research note. Credit Suisse Group downgraded GoHealth from a “neutral” rating to an “underperforming” rating and lowered its target price for the company from $6.00 to $3.00 in a Friday 7 research report. January. Bank of America downgraded GoHealth from a “buy” rating to an “underperform” rating and reduced its target price for the company from $7.50 to $3.50 in a Wednesday, Jan. 5, report. Finally, Zacks Investment Research downgraded GoHealth from a “hold” rating to a “strong sell” rating in a Wednesday, Jan. 5 research note.

(A d)

Small cap stocks – and penny stocks in particular – tend to march to the beat of their own beater.

Low-priced, “penny” stocks like these offer a great way to make money regardless of the direction of the markets as a whole…

Click here to see how you can get the names and stock symbols of the four penny stocks.

NASDAQ:GOCO shares opened at $1.14 on Tuesday. GoHealth has a 12-month minimum of $1.05 and a 12-month maximum of $12.68. The stock’s 50-day moving average is $2.50. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt ratio of 0.51. The company has a market capitalization of $365.61 million, a price-earnings ratio of 12.67 and a beta of 1.13.

A number of hedge funds and other institutional investors have recently changed their positions in GOCO. FNY Investment Advisers LLC bought a new stock position in GoHealth during Q4, valued at approximately $27,000. Metropolitan Life Insurance Co NY bought a new position in GoHealth in Q2 worth approximately $33,000. North Star Investment Management Corp. increased its stake in GoHealth by 41.6% in the third quarter. North Star Investment Management Corp. now owns 7,060 shares of the company worth $36,000 after purchasing an additional 2,075 shares in the last quarter. Ausdal Financial Partners Inc. purchased a new stake in GoHealth stock during Q4 for approximately $39,000. Finally, Teacher Retirement System of Texas purchased a new stake in GoHealth in the fourth quarter worth approximately $42,000. 46.73% of the shares are currently held by institutional investors and hedge funds.

GoHealth Company Profile (Get an assessment)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. It operates through four segments: MedicareÂInternal; Medicare External; Individual and Family Plans (IFP) and Other Internal; and Individual and family plans and other external.

Read more

Analyst Recommendations for GoHealth (NASDAQ: GOCO)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in GoHealth right now?

Before you consider GoHealth, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and GoHealth wasn’t on the list.

While GoHealth currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here


Comments are closed.